AnalystsNaz RahmanNaz Rahman's Stock Forecasts
AnalystsNaz Rahman
Analyst Ranking
Bottom 1%
#5542 out of 5550 analysts
Average Return
-34.1%
Win Rate
24%10 out of 42
Risk vs Reward
Poor
Good
Naz Rahman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | +166.34% | $7.19 | $19.15 | 2022-12-20 - 2023-12-19 | Strong Buy |
Scpharmaceuticals IncSCPH | +88.37% | $3.01 | $5.67 | 2025-03-20 - 2025-10-06 | Strong Buy |
Scpharmaceuticals IncSCPH | +73.13% | $4.80 | $8.31 | 2022-08-02 - 2023-08-01 | Strong Buy |
Kazia Therapeutics LtdKZIA | +50.08% | $6.31 | $9.47 | 2025-10-02 - 2026-10-01 | Strong Buy |
Alpha Cognition IncACOG | +41.20% | $6.19 | $8.74 | 2026-05-29 - 2026-10-30 | Strong Buy |
Naz Rahman Analyst Color
Get additional color on Naz Rahman's coverage of popular stocks
Naz Rahman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nasus Pharma LtdNSRX | 1 | Strong Buy | $7.00 | +128.01% | Initiates Coverage On | 19 hours ago |
Nexgel IncNXGL | 3 | Hold | N/A | N/A | Downgrades | 2 months ago |
Alpha Cognition IncACOG | 1 | Strong Buy | $12.00 | +37.30% | Initiates Coverage On | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 2 | Strong Buy | $575.00 | +2.88% | Upgrades | 7 months ago |
Scienture Holdings IncSCNX | 1 | Strong Buy | $37.50 | +1,064.60% | Initiates Coverage On | 8 months ago |
Kazia Therapeutics LtdKZIA | 1 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Aytu Biopharma IncAYTU | 2 | Strong Buy | $7.00 | N/A | Maintains | a year ago |
Scpharmaceuticals IncSCPH | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Eocene LtdEOCN | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Nuvectis Pharma IncNVCT | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Silexion Therapeutics CorpSLXN | 2 | Strong Buy | $750.00 | N/A | Maintains | 2 years ago |
Viking Therapeutics IncVKTX | 5 | Strong Buy | $70.00 | N/A | Maintains | 2 years ago |
Neurosense Therapeutics LtdNRSN | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Cingulate IncCING | 4 | Strong Buy | N/A | N/A | Upgrades | 2 years ago |
Palisade Bio IncPALI | 6 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Prf Technologies LtdPRFX | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Virpax Pharmaceuticals IncVRPX | 4 | Hold | N/A | N/A | Downgrades | 2 years ago |
Assertio Holdings IncASRT | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 2 years ago |
Alimera Sciences IncALIM | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Agile Therapeutics IncAGRX | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Quoin Pharmaceuticals LtdQNRX | 2 | Strong Buy | $140.00 | N/A | Maintains | 3 years ago |
Petros Pharmaceuticals IncPTPI | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |
Processa Pharmaceuticals IncPCSA | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Amryt Pharma PLCAMYT | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.